(PO-039) Expanding the Role of Psychiatrists to Increase COVID-19 Vaccination Rates in Clozapine-treated Patients with Serious Mental Illness: A Quality Improvement Project

por Lim, Carol, Freudenreich, Oliver, Van Alphen, Manjola, Maclaurin, Sarah
Publicado 2022

(21) Motivating and Mobilizing: Leveraging Psychiatric Providers and Settings to Maximize Vaccinations among Individuals with Serious Mental Illness

por Lim, Carol, Van Alphen, Manjola, Maclaurin, Sarah, Wright, Tyler, Freudenreich, Oliver
Publicado 2022

Clozapine Toxicity in the Setting of COVID-19

por Dotson, Samuel, Hartvigsen, Nathan, Wesner, Tara, Carbary, Timothy J., Fricchione, Gregory, Freudenreich, Oliver
Publicado 2020

Depressogenic effects of medications: a review

por Celano, Christopher M., Freudenreich, Oliver, Fernandez-Robles, Carlos, Stern, Theodore A., Caro, Mario A., Huffman, Jeff C.
Publicado 2011

A placebo-controlled study of sildenafil effects on cognition in schizophrenia

por Goff, Donald C., Cather, Corinne, Freudenreich, Oliver, Henderson, David C., Evins, A. Eden, Culhane, Melissa A., Walsh, Jared P.
Publicado 2008

S94. INTEGRATED DIABETES MANAGEMENT FOR INDIVIDUALS WITH SERIOUS MENTAL ILLNESS

por Cieslak, Kristina, Cather, Corinne, Maclaurin, Sarah, Wexler, Deborah, Thorndike, Anne, Chang, Trina, Pachas, Gladys, Vilme, Mike, Freudenreich, Oliver, Evins, Anne Eden
Publicado 2018

Hippocampal Subfield Volumes Predict Disengagement from Maintenance Treatment in First Episode Schizophrenia

por Qi, Wei, Marx, Julia, Zingman, Michael, Li, Yi, Petkova, Eva, Blessing, Esther, Ardekani, Babak, Sakalli Kani, Ayse, Cather, Corinne, Freudenreich, Oliver, Holt, Daphne, Zhao, Jingping, Wang, Jijun, Goff, Donald C
Publicado 2022